AI-generated summary
The authors reviewed five recent Western clinical practice guidelines for treating depression, focusing on their chronobiological recommendations. They report that most guidelines address chronobiology only briefly, with tentative support for agomelatine in major depression and bright light therapy in seasonal affective disorder. Limits include a lack of reliable therapeutic markers for chronotherapeutics.
- Limits stated in the abstract
- The abstract states that recommendations are limited by the lack of reliable therapeutic markers for chronotherapeutics and that evidence for non-seasonal depression is insufficient.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.